SUR, D.; HAVASI, A.; LUNGULESCU, C. V.; VOLOVAT, S. R.; BURZ, C.; IRIMIE, A. Endoglin (CD105) as a putative prognostic biomarker for colorectal cancer: a systematic review. Medicine and Pharmacy Reports, [S. l.], v. 95, n. 3, p. 251–259, 2022. DOI: 10.15386/mpr-2120. Disponível em: https://medpharmareports.com/index.php/mpr/article/view/2120. Acesso em: 1 jun. 2025.